×
For best experience we recommend to activate Javascript in your browser.
FGF9 antibody (AA 1-208)
The Mouse Monoclonal anti-FGF9 antibody (Clone E8) (ABIN7617351) specifically detects FGF9 in WB, IHC, IP and ICC.
The antibody is reactive with Human samples.
Catalog No. ABIN7617351
$484.57
Plus shipping costs $50.00
Delivery in 2 to 4 Business Days
Quick Overview for FGF9 antibody (AA 1-208) (ABIN7617351)
Target
See all FGF9 (FGF-9) Antibodies
FGF9 (FGF-9)
(Fibroblast Growth Factor 9 (FGF-9))
Reactivity
All reactivities for FGF9 antibodies
Human
Host
All hosts for FGF9 antibodies
Mouse
Clonality
All clonalities for FGF9 antibodies
Monoclonal
Conjugate
All conjugates for FGF9 antibodies
This FGF9 antibody is un-conjugated
Application
All applications for FGF9 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
E8
Product Details anti-FGF9 Antibody
(hide)
Binding Specificity
All epitopes for FGF9 antibodies
AA 1-208
Purpose
Fibroblast Growth Factor 9 (FGF9) Monoclonal Antibody
Sequence
Met1~Ser208
Characteristics
The Fibroblast Growth Factor 9 (FGF9) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG3 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for FGF9
(hide)
Target
FGF9 (FGF-9)
(Fibroblast Growth Factor 9 (FGF-9))
Alternative Name
FGF9
Gene ID
2254
UniProt
P31371
Recently viewed
(hide)
Chat with us , powered by LiveChat